Heart Rhythm
Volume 6, Issue 5 , Pages 611-612 , May 2009

The Sprint Fidelis story: Where are we now?

  • Charles A. Henrikson, MD, MPH

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Dr. Charles Henrikson, Division of Cardiology, Carnegie 592, Johns Hopkins University, 600 North Wolfe Street, Baltimore, Maryland 21205

References 

  1. Urgent Medical Device Information: Sprint Fidelis Lead Patient Management Recommendations. Available at: http://www.medtronic.com/product-advisories/physician/sprint-fidelis/PROD-ADV-PHYS-OCT.htm.
  2. Hauser RG, Kallinen LM, Almquist AK, et al. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm. 2007;4:892–896
  3. Farwell D, Green MS, Lemery R, et al. Accelerating risk of Fidelis lead fracture. Heart Rhythm. 2008;5:1375–1379
  4. Krahn AD, Champagne J, Healey JS, et al. Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm. 2008;5:639–642
  5. Ellenbogen KA, Wood MA, Swerdlow CD. The Sprint Fidelis lead fracture story: what do we really know and where do we go from here?. Heart Rhythm. 2008;5:1380–1381
  6. Krahn AD, Simpson CS, Parkash R, et al. Utilization of a national network for rapid response to the Medtronic Fidelis lead advisory: the Canadian Heart Rhythm Society Device Advisory Committee. Heart Rhythm. 2009;6:474–477
  7. Swerdlow CD, Ellenbogen KA. The changing presentation of implantable-cardioverter defibrillator lead fractures. Heart Rhythm. 2009;6:478–479
  8. Hauser RG, Hayes DL. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm. 2009;6:605–610
  9. Task Force on Lead Performance. Available at: http://www.hrsonline.org/News/taskforce_leadperformance.cfm.
  10. Kallinen LM, Hauser RG, Lee KW, et al. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm. 2008;5:775–779
  11. Kay GN, Brinker JA, Kawanishi DT, et al. Risks of spontaneous injury and extraction of an active fixation pacemaker lead: report of the Accufix Multicenter Clinical Study and Worldwide Registry. Circulation. 1999;100:2344–2352
  12. Glikson M, Suleiman M, Luria DM, et al. Do abandoned leads pose risk to implantable cardioverter-defibrillator patients?. Heart Rhythm. 2009;6:65–68

 Dr. Henrikson has received minor consulting fees from Boston Scientific.

PII: S1547-5271(09)00291-4

doi: 10.1016/j.hrthm.2009.03.016

Heart Rhythm
Volume 6, Issue 5 , Pages 611-612 , May 2009

Article Tools